Cargando…

KL-6 in ARDS and COVID-19 Patients

The Acute Respiratory Distress Syndrome (ARDS) is a common, devastating clinical pattern characterized by life-threatening respiratory failure. In ARDS there is an uncontrolled inflammatory response that results in alveolar damage, with the exudation of protein-rich pulmonary-edema fluid in the alve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piazza, Ornella, Scarpati, Giuliana, Boccia, Giovanni, Boffardi, Massimo, Pagliano, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università di Salerno 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673987/ https://www.ncbi.nlm.nih.gov/pubmed/36447946 http://dx.doi.org/10.37825/2239-9754.1035

Ejemplares similares

Krebs von den Lungen 6 (KL-6) levels in COVID-19 ICU patients are associated with mortality
por: Scarpati, Giuliana, et al.
Publicado: (2022)

KL-6 levels in COVID-19
por: Scarpati, G, et al.
Publicado: (2020)

COVID-19: a confirmed case of reinfection in a nurse
por: Scarpati, Giuliana, et al.
Publicado: (2021)

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
por: Scarpati, Giuliana, et al.
Publicado: (2021)

Experimental Pharmacotherapy for COVID-19: The Latest Advances
por: Pagliano, Pasquale, et al.
Publicado: (2021)

Comment on Guerrero-Romero et al. Magnesium-to-Calcium Ratio and Mortality from COVID-19. Nutrients 2022, 14, 1686
por: Scarpati, Giuliana, et al.
Publicado: (2022)

Update on transfusion solutions during surgery: review of hydroxyethyl starches 130/0.4
por: Piazza, Ornella, et al.
Publicado: (2010)

Translating the Results of a Selective Decontamination of the Digestive Tract Trial into Efficacious Real-Life Interventions
por: Piazza, Ornella, et al.
Publicado: (2022)

Serial KL-6 measurements in COVID-19 patients
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Thrombin antithrombin complex and IL-18 serum levels in stroke patients
por: Piazza, Ornella, et al.
Publicado: (2010)

Usefulness of KL-6 for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
por: Park, Mikyoung, et al.
Publicado: (2022)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Predictor factors for non-invasive mechanical ventilation failure in severe COVID-19 patients in the intensive care unit: a single-center retrospective study
por: Romanelli, Antonio, et al.
Publicado: (2022)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Could KL-6 levels in COVID-19 help to predict lung disease?
por: Frix, AN, et al.
Publicado: (2020)

Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumonia
por: Kim, Si-Ho, et al.
Publicado: (2022)

Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
por: Scotto, Riccardo, et al.
Publicado: (2021)

Keynote Lectures (KL)
Publicado: (2017)

Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy)
por: Ciccarelli, Michele, et al.
Publicado: (2022)

Peak value of serum KL-6 may be useful for predicting poor prognosis of severe COVID-19 patients
por: Maruyama, Shuhei, et al.
Publicado: (2022)

Krebs von den Lungen-6 (KL-6) Levels in Post-COVID Follow-Up: Differences According to the Severity of COVID-19
por: Carpio, Carlos, et al.
Publicado: (2023)

Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis
por: Ohnishi, Hiroshi, et al.
Publicado: (2014)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19
por: Azekawa, Shuhei, et al.
Publicado: (2023)

Prediction Value of KREBS Von Den Lungen-6 (KL-6) Biomarker in COVID-19 Patients: A Systematic Review and Meta-Analysis
por: Matuszewski, Michal, et al.
Publicado: (2022)

Impact of Ninjin’yoeito on frailty and short life in klotho-hypomorphic (kl/kl) mice
por: Amitani, Haruka, et al.
Publicado: (2022)

Draft Genome Sequences of Pseudomonas moraviensis UCD-KL30, Vibrio ostreicida UCD-KL16, Colwellia sp. Strain UCD-KL20, Shewanella sp. Strain UCD-KL12, and Shewanella sp. Strain UCD-KL21, Isolated from Seagrass
por: Lujan, Karley M., et al.
Publicado: (2017)

D-dimer levels in non-COVID-19 ARDS and COVID-19 ARDS patients: A systematic review with meta-analysis
por: Tóth, Krisztina, et al.
Publicado: (2023)

Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients
por: Bocci, Silvia, et al.
Publicado: (2023)

Review of Kl3 theory
por: Callan, C
Publicado: (1969)

Role of Krebs von den Lungen-6 (KL-6) in Assessing Hypersensitivity Pneumonitis
por: Mostafa, Amira Ismail, et al.
Publicado: (2021)

The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients
por: Karadeniz, Hazan, et al.
Publicado: (2022)

Serum KL-6 is a predictor of outcome in pulmonary alveolar proteinosis
por: Bonella, Francesco, et al.
Publicado: (2013)

BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6
por: Tobiume, Makoto, et al.
Publicado: (2014)

Establishing Sex-Dependent Reference Intervals for KL-6 in Danish Adults
por: Bruun, Stine Bakkensen, et al.
Publicado: (2023)

Measurement of the KL0 → $\pi \mu \nu$ absolute decay rate; further results on KL0 → $\pi$ e $\nu$ , and measurement of the KL0 mean life
por: Lowys, J P, et al.
Publicado: (1967)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses
por: Naderi, Nadereh, et al.
Publicado: (2022)

Association of serum KL-6 levels on COVID-19 severity: A cross-sectional study design with purposive sampling
por: Suryananda, Titah Dhadhari, et al.
Publicado: (2021)

Fatigue as long-term consequence of ARDS in COVID-19 patients
por: Zuin, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16b5i9glmbnn5k73kbolko84dv